Although integrated care pathways (ICPs) are used widely in acute hospitals for conditions, such as fractured neck of femur, they have not been widely adopted in more complex or unpredictable areas such as mental health1,2. In Rotherham we have been developing ICPs in mental health for the past two years in a variety of areas, including an electro-convulsive (ECT) clinic, an inpatient rehabilitation unit and treatment with atypical antipsychotics. This paper outlines our rationale for, and experiences of, developing an ICP for our locally run clozapine clinic.
References
1.
JohnsonS. Variance tracking from an effective pathway process. Health Care Risk Report1997/98; 4: 1–6
2.
JohnsonS. Use of ICPs to manage unpredictable situations. Professional Nurse2000; 16: 956–8
3.
National Institute for Clinical Excellence.Guidance on the use of newer (atypical) antipsychotic drugs for the treatment of schizophrenia. Technology Appraisal Guidance No. 43. London: NICE, 2002
4.
British Medical Association.British national formulary.London: Pharmaceutical Press, 2004
5.
CamprubiMBagaryMRiccioM. The clozapine clinic. Lancet1996; 347: 124
6.
PeetMWakefieldS. Integrated care pathways in mental health: The need for the human touch. Journal of Integrated Care Pathways2002; 6: 108–14
7.
de LucK. Care pathways: An evaluation of their effectiveness. Journal of Advanced Nursing2000; 32: 485–96
8.
WakefieldSPeetM. Developing integrated care pathways in mental health: The critical success factors. Journal of Integrated Care Pathways2003; 7: 47–49
